van Zandvoort, K;
Hassan, AI;
Bobe, MO;
Pell, CL;
Ahmed, MS;
Ortika, BD;
Ibrahim, S;
Abdi, MI;
Karim, MA;
Eggo, RM;
et al.
van Zandvoort, K; Hassan, AI; Bobe, MO; Pell, CL; Ahmed, MS; Ortika, BD; Ibrahim, S; Abdi, MI; Karim, MA; Eggo, RM; Ali, SY; Hinds, J; Soleman, SM; Cummings, R; McGowan, CR; Mulholland, EK; Hergeye, MA; Satzke, C; Checchi, F; Flasche, S
(2024)
Pre-vaccination carriage prevalence of Streptococcus pneumoniae serotypes among internally displaced people in Somaliland: a cross-sectional study.
Pneumonia (Nathan), 16 (1).
p. 25.
ISSN 2200-6133
https://doi.org/10.1186/s41479-024-00148-6
SGUL Authors: Hinds, Jason
Abstract
BACKGROUND: Populations affected by humanitarian crises likely experience high burdens of pneumococcal disease. Streptococcus pneumoniae carriage estimates are essential to understand pneumococcal transmission dynamics and the potential impact of pneumococcal conjugate vaccines (PCV). Over 100 million people are forcibly displaced worldwide, yet here we present only the second pneumococcal carriage estimates for a displaced population. METHODS: In October 2019, we conducted a cross-sectional survey among internally displaced people (IDP) living in Digaale, a permanent IDP camp in Somaliland where PCV has not been implemented. We collected nasopharyngeal swab samples from 453 residents which were assessed for presence of pneumococci and serotyped using DNA microarray. RESULTS: We found that pneumococcal carriage prevalence was 36% (95%CI 31-40) in all ages, and 70% (95%CI 64-76) in children under 5. The three most common serotypes were vaccine serotypes 6B, 19F, and 23F. We estimated that the serotypes included in the 10-valent PNEUMOSIL vaccine were carried by 41% (95%CI 33-49) of all pneumococcal carriers and extrapolated that they caused 52% (95%CI 35-70) of invasive pneumococcal disease. We found some evidence that pneumococcal carriage was associated with recent respiratory symptoms, the total number of physical contacts made, and with malnutrition in children under 5. Through linking with a nested contact survey we projected that pneumococcal exposure of children under 2 was predominantly due to contact with children aged 2-5 (39%; 95%CI 31-48) and 6-14 (25%; 95%CI 17-34). CONCLUSIONS: These findings suggest considerable potential for direct and indirect protection against pneumococcal disease in Digaale through PCV use in children and potentially adolescents.
Item Type: |
Article
|
Additional Information: |
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: |
Streptococcus pneumoniae, Displaced population, Humanitarian crisis, Pneumococcal conjugate vaccine, Somaliland, <italic>Streptococcus pneumoniae</italic>, Displaced population, Humanitarian crisis, Pneumococcal conjugate vaccine, Somaliland, 1199 Other Medical and Health Sciences |
SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: |
Pneumonia (Nathan) |
ISSN: |
2200-6133 |
Language: |
eng |
Dates: |
Date | Event |
---|
5 December 2024 | Published | 23 September 2024 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
Projects: |
Project ID | Funder | Funder ID |
---|
UNSPECIFIED | Wellcome Trust | UNSPECIFIED | 208812/Z/17/Z | Wellcome Trust | UNSPECIFIED | NIHR200908 | National Institute for Health and Care Research | UNSPECIFIED |
|
PubMed ID: |
39633426 |
Web of Science ID: |
WOS:001370220900001 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/117010 |
Publisher's version: |
https://doi.org/10.1186/s41479-024-00148-6 |
Statistics
Item downloaded times since 16 Dec 2024.
Actions (login required)
|
Edit Item |